//
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
Long-term effects of intensive glucose lowering on cardiovascular outcomes
Sox17 Controls Emergence and Remodeling of Nestin-Expressing Coronary Vessels
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk
2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines
Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings
Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients
Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation